Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 515

1.

Hepatitis B Virus Genotype-Dependent Vulnerability of Infected Cells to Immune Reaction in the Early Phase of Infection.

Shiina M, Yamada N, Sugiyama R, Murayama A, Aly HH, Muramatsu M, Wakita T, Imawari M, Kato T.

Front Microbiol. 2019 Oct 18;10:2427. doi: 10.3389/fmicb.2019.02427. eCollection 2019.

2.

Surfeit 4 contributes to the replication of hepatitis C virus using double membrane vesicles.

Kong L, Aoyagi H, Yang Z, Ouyang T, Matsuda M, Fujimoto A, Watashi K, Suzuki R, Arita M, Yamagoe S, Dohmae N, Suzuki T, Suzuki T, Muramatsu M, Wakita T, Aizaki H.

J Virol. 2019 Oct 23. pii: JVI.00858-19. doi: 10.1128/JVI.00858-19. [Epub ahead of print]

PMID:
31645450
3.

The GP Score, a Simplified Formula (Bioptic Gleason Score Times Prostate Specific Antigen) as a Predictor for Biochemical Failure after Prostatectomy in Prostate Cancer.

Soga N, Ogura Y, Wakita T, Kageyama T, Furusawa J.

Curr Urol. 2019 Sep;13(1):25-30. doi: 10.1159/000499298. Epub 2019 Sep 10.

4.

SARC-F Validation and SARC-F+EBM Derivation in Musculoskeletal Disease: The SPSS-OK Study.

Kurita N, Wakita T, Kamitani T, Wada O, Mizuno K.

J Nutr Health Aging. 2019;23(8):732-738. doi: 10.1007/s12603-019-1222-x.

PMID:
31560031
5.

Cell Culture Systems of HCV Using JFH-1 and Other Strains.

Wakita T.

Cold Spring Harb Perspect Med. 2019 Nov 1;9(11). pii: a036806. doi: 10.1101/cshperspect.a036806. Review.

PMID:
31501261
6.

Integrin α3 is involved in non-enveloped hepatitis E virus infection.

Shiota T, Li TC, Nishimura Y, Yoshizaki S, Sugiyama R, Shimojima M, Saijo M, Shimizu H, Suzuki R, Wakita T, Muramatsu M, Ishii K.

Virology. 2019 Oct;536:119-124. doi: 10.1016/j.virol.2019.07.025. Epub 2019 Jul 30.

7.

Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.

Toyama M, Sakakibara N, Takeda M, Okamoto M, Watashi K, Wakita T, Sugiyama M, Mizokami M, Ikeda M, Baba M.

Virus Res. 2019 Oct 2;271:197677. doi: 10.1016/j.virusres.2019.197677. Epub 2019 Jul 31.

PMID:
31376401
8.

Asymmetric Phosphorus Incorporation in Homoepitaxial P-Doped (111) Diamond Revealed by Photoelectron Holography.

Yokoya T, Terashima K, Takeda A, Fukura T, Fujiwara H, Muro T, Kinoshita T, Kato H, Yamasaki S, Oguchi T, Wakita T, Muraoka Y, Matsushita T.

Nano Lett. 2019 Sep 11;19(9):5915-5919. doi: 10.1021/acs.nanolett.9b01481. Epub 2019 Aug 21.

PMID:
31373825
9.

Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure.

Hatanaka T, Naganuma A, Tateyama Y, Yoshinari F, Hoshino T, Sato K, Hmwe SS, Aizaki H, Wakita T, Kakizaki S, Uraoka T.

Intern Med. 2019 Oct 15;58(20):2969-2975. doi: 10.2169/internalmedicine.2982-19. Epub 2019 Jun 27.

10.

Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems.

Nio Y, Sasai M, Akahori Y, Okamura H, Hasegawa H, Oshima M, Watashi K, Wakita T, Ryo A, Tanaka Y, Hijikata M.

Antiviral Res. 2019 Sep;169:104537. doi: 10.1016/j.antiviral.2019.104537. Epub 2019 Jun 14.

PMID:
31207277
11.

An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes.

Furutani Y, Toguchi M, Shiozaki-Sato Y, Qin XY, Ebisui E, Higuchi S, Sudoh M, Suzuki H, Takahashi N, Watashi K, Wakita T, Kakeya H, Kojima S.

PLoS One. 2019 Jun 12;14(6):e0216139. doi: 10.1371/journal.pone.0216139. eCollection 2019.

12.

Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People's Democratic Republic.

Norizuki M, Kitamura T, Komada K, Sugiyama M, Mizokami M, Xeuatvongsa A, Som-Oulay V, Vongphrachanh P, Machida M, Wada K, Ishii K, Kiyohara T, Wakita T, Hachiya M.

BMC Infect Dis. 2019 Jun 10;19(1):507. doi: 10.1186/s12879-019-4086-0.

13.

Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection.

Murayama A, Momose H, Yamada N, Hoshi Y, Muramatsu M, Wakita T, Ishimaru K, Hamaguchi I, Kato T.

J Clin Virol. 2019 Aug;117:37-42. doi: 10.1016/j.jcv.2019.05.011. Epub 2019 May 29.

PMID:
31176210
14.

Discovery of broflanilide, a novel insecticide.

Katsuta H, Nomura M, Wakita T, Daido H, Kobayashi Y, Kawahara A, Banba S.

J Pestic Sci. 2019 May 20;44(2):120-128. doi: 10.1584/jpestics.D18-088.

15.

Human-rat chimeric anti-occludin monoclonal antibodies inhibit hepatitis C virus infection.

Shimizu Y, Yoneda K, Shirasago Y, Suzuki T, Tada M, Ishii-Watabe A, Sugiyama K, Suzuki T, Wakita T, Yagi K, Kondoh M, Fukasawa M.

Biochem Biophys Res Commun. 2019 Jun 30;514(3):785-790. doi: 10.1016/j.bbrc.2019.05.019. Epub 2019 May 9.

PMID:
31079928
16.

Retrotransposon elements among initial sites of hepatitis B virus integration into human genome in the HepG2-NTCP cell infection model.

Chauhan R, Shimizu Y, Watashi K, Wakita T, Fukasawa M, Michalak TI.

Cancer Genet. 2019 Jun;235-236:39-56. doi: 10.1016/j.cancergen.2019.04.060. Epub 2019 Apr 24.

PMID:
31064734
17.

Inhibition Mechanisms of Hepatitis C Virus Infection by Caffeic Acid and Tannic Acid.

Shirasago Y, Inamori Y, Suzuki T, Tanida I, Suzuki T, Sugiyama K, Wakita T, Hanada K, Fukasawa M.

Biol Pharm Bull. 2019;42(5):770-777. doi: 10.1248/bpb.b18-00970.

18.

miR-27b-mediated suppression of aquaporin-11 expression in hepatocytes reduces HCV genomic RNA levels but not viral titers.

Sakurai F, Hashimoto R, Inoue C, Wakabayashi K, Tsukamoto T, Imaizumi T, Andres TGM, Sakai E, Itsuki K, Sakamoto N, Wakita T, Mizuguchi H.

Virol J. 2019 May 2;16(1):58. doi: 10.1186/s12985-019-1160-6.

19.

Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.

Iwamoto M, Saso W, Sugiyama R, Ishii K, Ohki M, Nagamori S, Suzuki R, Aizaki H, Ryo A, Yun JH, Park SY, Ohtani N, Muramatsu M, Iwami S, Tanaka Y, Sureau C, Wakita T, Watashi K.

Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8487-8492. doi: 10.1073/pnas.1811064116. Epub 2019 Apr 5.

20.

Current status of hepatitis E virus infection at a rhesus monkey farm in China.

Yang F, Duan S, Guo Y, Li Y, Yoshizaki S, Takeda N, Wakita T, Muramatsu M, Zhao Y, He Z, Li TC.

Vet Microbiol. 2019 Mar;230:244-248. doi: 10.1016/j.vetmic.2019.01.021. Epub 2019 Feb 13.

PMID:
30827396
21.

Concept of Viral Inhibitors via NTCP.

Fukano K, Tsukuda S, Watashi K, Wakita T.

Semin Liver Dis. 2019 Feb;39(1):78-85. doi: 10.1055/s-0038-1676804. Epub 2019 Jan 17. Review.

PMID:
30809790
22.

Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor.

Takeuchi F, Ikeda S, Tsukamoto Y, Iwasawa Y, Qihao C, Otakaki Y, Ryota O, Yao WL, Narita R, Makoto H, Watashi K, Wakita T, Takeuchi K, Chayama K, Kogure A, Kato H, Fujita T.

PLoS One. 2019 Feb 19;14(2):e0212233. doi: 10.1371/journal.pone.0212233. eCollection 2019.

23.

Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase.

Suzuki R, Matsuda M, Shimoike T, Watashi K, Aizaki H, Kato T, Suzuki T, Muramatsu M, Wakita T.

Virology. 2019 Mar;529:226-233. doi: 10.1016/j.virol.2019.01.024. Epub 2019 Jan 29.

PMID:
30738360
24.

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes.

Fukano K, Tsukuda S, Oshima M, Suzuki R, Aizaki H, Ohki M, Park SY, Muramatsu M, Wakita T, Sureau C, Ogasawara Y, Watashi K.

Front Microbiol. 2019 Jan 8;9:3257. doi: 10.3389/fmicb.2018.03257. eCollection 2018.

25.

Genotype 5 Hepatitis E Virus Produced by a Reverse Genetics System Has the Potential for Zoonotic Infection.

Li TC, Bai H, Yoshizaki S, Ami Y, Suzaki Y, Doan YH, Takahashi K, Mishiro S, Takeda N, Wakita T.

Hepatol Commun. 2018 Nov 30;3(1):160-172. doi: 10.1002/hep4.1288. eCollection 2019 Jan.

26.

Origins of Thermal Spin Depolarization in Half-Metallic Ferromagnet CrO_{2}.

Fujiwara H, Terashima K, Sunagawa M, Yano Y, Nagayama T, Fukura T, Yoshii F, Matsuura Y, Ogata M, Wakita T, Yaji K, Harasawa A, Kuroda K, Shin S, Horiba K, Kumigashira H, Muraoka Y, Yokoya T.

Phys Rev Lett. 2018 Dec 21;121(25):257201. doi: 10.1103/PhysRevLett.121.257201.

PMID:
30608774
27.

Establishment of Replication-Competent HCV Strain with Minimum Modifications.

Kato T, Murayama A, Wakita T.

Methods Mol Biol. 2019;1911:73-83. doi: 10.1007/978-1-4939-8976-8_4.

PMID:
30593618
28.

Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.

Deng L, Gan X, Ito M, Chen M, Aly HH, Matsui C, Abe T, Watashi K, Wakita T, Suzuki T, Okamoto T, Matsuura Y, Mizokami M, Shoji I, Hotta H.

J Virol. 2019 Mar 5;93(6). pii: e02203-18. doi: 10.1128/JVI.02203-18. Print 2019 Mar 15.

29.

Fermi surface topology in a metallic phase of VO2 thin films grown on TiO2(001) substrates.

Muraoka Y, Nagao H, Yao Y, Wakita T, Terashima K, Yokoya T, Kumigashira H, Oshima M.

Sci Rep. 2018 Dec 17;8(1):17906. doi: 10.1038/s41598-018-36281-8.

30.

A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity.

Takeuchi JS, Fukano K, Iwamoto M, Tsukuda S, Suzuki R, Aizaki H, Muramatsu M, Wakita T, Sureau C, Watashi K.

J Virol. 2019 Feb 19;93(5). pii: e01432-18. doi: 10.1128/JVI.01432-18. Print 2019 Mar 1.

31.

Acidic polysaccharides isolated from marine algae inhibit the early step of viral infection.

Ueno M, Nogawa M, Siddiqui R, Watashi K, Wakita T, Kato N, Ikeda M, Okimura T, Isaka S, Oda T, Ariumi Y.

Int J Biol Macromol. 2019 Mar 1;124:282-290. doi: 10.1016/j.ijbiomac.2018.11.152. Epub 2018 Nov 16.

PMID:
30452989
32.

High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon.

Matsuda M, Yamanaka A, Yato K, Yoshii K, Watashi K, Aizaki H, Konishi E, Takasaki T, Kato T, Muramatsu M, Wakita T, Suzuki R.

Sci Rep. 2018 Nov 9;8(1):16624. doi: 10.1038/s41598-018-34865-y.

33.

The aryl hydrocarbon receptor-cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assembly.

Ohashi H, Nishioka K, Nakajima S, Kim S, Suzuki R, Aizaki H, Fukasawa M, Kamisuki S, Sugawara F, Ohtani N, Muramatsu M, Wakita T, Watashi K.

J Biol Chem. 2018 Dec 21;293(51):19559-19571. doi: 10.1074/jbc.RA118.005033. Epub 2018 Oct 31.

PMID:
30381393
34.

Vitamin D derivatives inhibit hepatitis C virus production through the suppression of apolipoprotein.

Murayama A, Saitoh H, Takeuchi A, Yamada N, Matsumura T, Shiina M, Muramatsu M, Wakita T, Imawari M, Kato T.

Antiviral Res. 2018 Dec;160:55-63. doi: 10.1016/j.antiviral.2018.10.014. Epub 2018 Oct 16.

PMID:
30339849
35.

Suppression of structural instability in LaOBiS2-x Se x by Se substitution.

Paris E, Mizuguchi Y, Wakita T, Terashima K, Yokoya T, Mizokawa T, Saini NL.

J Phys Condens Matter. 2018 Nov 14;30(45):455703. doi: 10.1088/1361-648X/aae501.

PMID:
30265246
36.

Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.

Hu J, Lin YY, Chen PJ, Watashi K, Wakita T.

Gastroenterology. 2019 Jan;156(2):338-354. doi: 10.1053/j.gastro.2018.06.093. Epub 2018 Sep 19. Review.

37.

Determination of the local structure of Sr2-xMxIrO4 (M = K, La) as a function of doping and temperature.

Terashima K, Paris E, Salas-Colera E, Simonelli L, Joseph B, Wakita T, Horigane K, Fujii M, Kobayashi K, Horie R, Akimitsu J, Muraoka Y, Yokoya T, Saini NL.

Phys Chem Chem Phys. 2018 Sep 19;20(36):23783-23788. doi: 10.1039/c8cp03756f.

PMID:
30199083
38.

Detection of Subgenotype IA and IIIA Hepatitis A Viruses in Rivers Flowing through Metro Manila, the Philippines.

Bai H, Shiota T, Yoshizaki S, Saito-Obata M, Malbas FF Jr, Lupisan SP, Oshitani H, Takeda N, Muramatsu M, Wakita T, Ishii K, Li TC.

Jpn J Infect Dis. 2019 Jan 23;72(1):53-55. doi: 10.7883/yoken.JJID.2018.148. Epub 2018 Aug 31.

39.

Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells.

Nie YZ, Zheng YW, Miyakawa K, Murata S, Zhang RR, Sekine K, Ueno Y, Takebe T, Wakita T, Ryo A, Taniguchi H.

EBioMedicine. 2018 Sep;35:114-123. doi: 10.1016/j.ebiom.2018.08.014. Epub 2018 Aug 16.

40.

Evaluation of antiviral effects of novel NS5A inhibitors in hepatitis C virus cell culture system with full-genome infectious clones.

Murayama A, Fujiwara K, Yamada N, Shiina M, Aly HH, Masaki T, Muramatsu M, Wakita T, Kato T.

Antiviral Res. 2018 Oct;158:161-170. doi: 10.1016/j.antiviral.2018.08.008. Epub 2018 Aug 15.

PMID:
30118732
41.

IL-1β/ATF3-mediated induction of Ski2 expression enhances hepatitis B virus x mRNA degradation.

Shiromoto F, Aly HH, Kudo H, Watashi K, Murayama A, Watanabe N, Zheng X, Kato T, Chayama K, Muramatsu M, Wakita T.

Biochem Biophys Res Commun. 2018 Sep 10;503(3):1854-1860. doi: 10.1016/j.bbrc.2018.07.126. Epub 2018 Jul 25.

PMID:
30055801
42.

Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.

Shirasago Y, Fukazawa H, Aizaki H, Suzuki T, Suzuki T, Sugiyama K, Wakita T, Hanada K, Abe R, Fukasawa M.

J Gen Virol. 2018 Oct;99(10):1407-1417. doi: 10.1099/jgv.0.001117. Epub 2018 Jul 27.

PMID:
30045785
43.

Evaluation of in vitro screening and diagnostic kits for hepatitis C virus infection.

Momose H, Matsuoka S, Murayama A, Yamada N, Okuma K, Ikebe E, Hoshi Y, Muramatsu M, Wakita T, Toyota K, Kato T, Hamaguchi I.

J Clin Virol. 2018 Aug;105:97-102. doi: 10.1016/j.jcv.2018.06.008. Epub 2018 Jun 11.

PMID:
29940422
44.

Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.

Kitamura K, Que L, Shimadu M, Koura M, Ishihara Y, Wakae K, Nakamura T, Watashi K, Wakita T, Muramatsu M.

PLoS Pathog. 2018 Jun 21;14(6):e1007124. doi: 10.1371/journal.ppat.1007124. eCollection 2018 Jun.

45.

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide.

Miyakawa K, Matsunaga S, Yamaoka Y, Dairaku M, Fukano K, Kimura H, Chimuro T, Nishitsuji H, Watashi K, Shimotohno K, Wakita T, Ryo A.

Oncotarget. 2018 May 4;9(34):23681-23694. doi: 10.18632/oncotarget.25348. eCollection 2018 May 4.

46.

Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction.

Tsukamoto Y, Ikeda S, Uwai K, Taguchi R, Chayama K, Sakaguchi T, Narita R, Yao WL, Takeuchi F, Otakaki Y, Watashi K, Wakita T, Kato H, Fujita T.

PLoS One. 2018 May 21;13(5):e0197664. doi: 10.1371/journal.pone.0197664. eCollection 2018.

47.

De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry.

Passioura T, Watashi K, Fukano K, Shimura S, Saso W, Morishita R, Ogasawara Y, Tanaka Y, Mizokami M, Sureau C, Suga H, Wakita T.

Cell Chem Biol. 2018 Jul 19;25(7):906-915.e5. doi: 10.1016/j.chembiol.2018.04.011. Epub 2018 May 17.

48.

Expression of a functional intrabody against hepatitis C virus core protein in Escherichia coli and silkworm pupae.

Kato T, Hasegawa M, Yamamoto T, Miyazaki T, Suzuki R, Wakita T, Suzuki T, Park EY.

Protein Expr Purif. 2018 Oct;150:61-66. doi: 10.1016/j.pep.2018.05.009. Epub 2018 May 18.

PMID:
29778543
49.

Evaluation of Heating Conditions for Inactivation of Hepatitis E Virus Genotypes 3 and 4.

Imagawa T, Sugiyama R, Shiota T, Li TC, Yoshizaki S, Wakita T, Ishii K.

J Food Prot. 2018 Jun;81(6):947-952. doi: 10.4315/0362-028X.JFP-17-290.

PMID:
29745758
50.

Small Animal Models of Hepatitis E Virus Infection.

Li TC, Wakita T.

Cold Spring Harb Perspect Med. 2019 Aug 1;9(8). pii: a032581. doi: 10.1101/cshperspect.a032581. Review.

PMID:
29735581

Supplemental Content

Loading ...
Support Center